MLL3-Mediated Changes in Chromatin Structure During Hematopoiesis by Gehred, Natalie
Washington University in St. Louis 
Washington University Open Scholarship 
Volume 12 Washington University Undergraduate Research Digest 
Spring 2017 
MLL3-Mediated Changes in Chromatin Structure During 
Hematopoiesis 
Natalie Gehred 
Washington University in St. Louis 
Follow this and additional works at: https://openscholarship.wustl.edu/wuurd_vol12 
Recommended Citation 
Gehred, Natalie, "MLL3-Mediated Changes in Chromatin Structure During Hematopoiesis" (2017). Volume 
12. 64. 
https://openscholarship.wustl.edu/wuurd_vol12/64 
This Abstracts A-I is brought to you for free and open access by the Washington University 
Undergraduate Research Digest at Washington University Open Scholarship. It has been accepted for inclusion in 
Volume 12 by an authorized administrator of Washington University Open Scholarship. For more information, 
please contact digital@wumail.wustl.edu. 
Toward a Better Understanding of...
110




The MLL3 gene encodes an epigenetic regulator thought to play a role in hematopoietic 
differentiation. Recent experiments in the Druley Lab suggest that MLL3-deficient iPSCs 
fail to form hemogenic endothelium, resulting in a lack of definitive hematopoiesis 
in these cell lines and potentially explaining why rare nonsynonymous germline 
mutations in MLL3 are implicated in the development of infant leukemia. The assay 
for transposase-accessible chromatin (ATAC-seq) can localize the structural changes in 
chromatin that accompany this change in hematopoietic potential by identifying peaks 
of open chromatin.
ATAC-seq peaks were compared between umbilical cord blood CD34+ stem cells 
(UCB), wild-type CD34+ iPSC cells (WT), and CD34+ MLL3-/- iPSC cells (KO). ATAC-
seq libraries were produced from 50,000 UCB, WT, and KO cells according to a modified 
ATAC-seq protocol (Semenkovich et al. PNAS, 2016). After Illumina sequencing, the 
reads were analyzed with the Kundaje Lab ATAC-seq pipeline to generate peak files of 
each sample. DiffBind was used to compare samples and identify regions of significant 
change between the negative controls and KO.
Comparison of UCB, WT, and KO samples has yielded a list of 4923 differentially-
called peaks, 248 of which were found within 3kb of a promoter, often of another known 
epigenetic regulator. 64% of these promoter peaks were increased in the KO sample.
 We conclude that MLL3-mediated changes in chromatin structure are widespread, 
often affecting the accessibility other epigenetic regulators in a way that correlates with 
their under- or over-expression in cancer. The focus of additional research will be to 
repeat these experiments and supplement ATAC-seq data with other epigenetic assays 
to provide a more complete view of the mechanisms of epigenetic regulation involved 
in hematopoiesis.
